The pathogenicity and multi-organ proteomic profiles of Mpox virus infection in SIVmac239-infected rhesus macaques

Dong Zhang1, Jiangfeng Liu2, Lin Zhu1

  • 1State Key Laboratory of Respiratory Health and Multimorbidity, NHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.

Nature Communications
|August 16, 2025
PubMed

Insights

Mpox (MPXV) is more severe in individuals with HIV. This study found increased MPXV replication and immune impairment in co-infected macaques, identifying potential therapeutic targets for mpox.

Area of Science:

  • Virology
  • Immunology
  • Proteomics

Background:

  • Mpox (MPXV) poses a severe risk to individuals with HIV.
  • The molecular mechanisms of multi-organ damage in mpox, especially with HIV co-infection, are unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms and immunopathology of mpox virus (MPXV) in the context of SIV co-infection.
  • To identify potential therapeutic targets for mpox.

Main Methods:

  • Comparative analysis of MPXV and SIV-MPXV co-infected rhesus macaques.
  • Multi-organ proteomic and phosphoproteomic analyses.

Main Results:

  • SIV-MPXV co-infection led to increased viral replication, extensive skin lesions, and impaired immune responses compared to MPXV alone.
  • Proteomic analysis revealed upregulated immune and inflammatory pathways in lesions and organs.
  • Abnormal DNA replication and cell cycle signaling pathways were observed, potentially enhancing viral replication.

Conclusions:

  • CDK4/6 may be a therapeutic target to suppress MPXV replication.
  • Proteomic data provides insights into mpox pathogenesis during SIV co-infection.
  • Findings support efforts to mitigate mpox impact.